Piperidine derivatives as modulators of chemokine receptor CCR5

Details for Australian Patent Application No. 2005235169 (hide)

Owner AstraZeneca AB

Inventors Tucker, Howard; Faull, Alan

Agent Freehills

Pub. Number AU-B-2005235169

PCT Pub. Number WO2005/101989

Priority 0401057-5 23.04.04 SE; 0500057-5 10.01.05 SE

Filing date 20 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 18 September 2008

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/101989 Priority application(s): WO2005/101989

18 September 2008 Application Accepted

  Published as AU-B-2005235169

22 January 2009 Standard Patent Sealed

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235171-Use of chondroitin sulphate E (CS-E) for the treatment diseases or conditions related to collagen fibril formation.

2005235168-Tissue enhancement implant and method